Large-scale molecular characterization and analysis of gastric cancer.
作者信息
Shmulevich Ilya
出版信息
Chin J Cancer. 2014 Aug;33(8):369-70. doi: 10.5732/cjc.014.10116.
Abstract
摘要
相似文献
1
Large-scale molecular characterization and analysis of gastric cancer.
Chin J Cancer. 2014 Aug;33(8):369-70. doi: 10.5732/cjc.014.10116.
2
The journey of personalizing gastric cancer treatment.
Chin J Cancer. 2016 Aug 31;35(1):84. doi: 10.1186/s40880-016-0149-4.
3
Identification of gastric microbiota biomarker for gastric cancer.
Chin Med J (Engl). 2020 Nov 20;133(22):2765-2767. doi: 10.1097/CM9.0000000000001081.
4
Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Expert Rev Proteomics. 2016 Dec;13(12):1131-1139. doi: 10.1080/14789450.2016.1249469. Epub 2016 Oct 31.
5
Incorporating molecular biomarkers into clinical practice for gastric cancer.
Expert Rev Anticancer Ther. 2019 Sep;19(9):757-771. doi: 10.1080/14737140.2019.1659136. Epub 2019 Aug 26.
6
Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.
Expert Rev Mol Med. 2014 Jan 23;16:e1. doi: 10.1017/erm.2013.16.
7
Biomarkers of Helicobacter pylori-associated gastric cancer.
Gut Microbes. 2013 Nov-Dec;4(6):532-40. doi: 10.4161/gmic.25720. Epub 2013 Jul 12.
8
Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer.
PLoS One. 2016 Aug 2;11(8):e0159424. doi: 10.1371/journal.pone.0159424. eCollection 2016.
9
Metaplasia in the Stomach-Precursor of Gastric Cancer?
Int J Mol Sci. 2017 Sep 27;18(10):2063. doi: 10.3390/ijms18102063.
10
A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Am J Gastroenterol. 2017 May;112(5):704-715. doi: 10.1038/ajg.2017.55. Epub 2017 Mar 21.
引用本文的文献
1
Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
J Pathol Clin Res. 2024 Jan;10(1):e343. doi: 10.1002/cjp2.343. Epub 2023 Nov 16.
2
Role of miR-647 in human gastric cancer suppression.
Oncol Rep. 2017 Mar;37(3):1401-1411. doi: 10.3892/or.2017.5383. Epub 2017 Jan 17.
3
LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.
Oncotarget. 2016 Jun 21;7(25):37812-37824. doi: 10.18632/oncotarget.9336.
4
Cancer research in the era of next-generation sequencing and big data calls for intelligent modeling.
Chin J Cancer. 2015 Apr 11;34(10):423-6. doi: 10.1186/s40880-015-0008-8.
5
Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.
Chin J Cancer. 2014 Dec;33(12):620-4. doi: 10.5732/cjc.014.10246. Epub 2014 Nov 21.
6
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics.
Chin J Cancer. 2014 Oct;33(10):469-70. doi: 10.5732/cjc.014.10117. Epub 2014 Sep 16.
本文引用的文献
1
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.
Zotero 插件